These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 27571186)

  • 1. Hyperandrogenism Accompanies Increased Intra-Abdominal Fat Storage in Normal Weight Polycystic Ovary Syndrome Women.
    Dumesic DA; Akopians AL; Madrigal VK; Ramirez E; Margolis DJ; Sarma MK; Thomas AM; Grogan TR; Haykal R; Schooler TA; Okeya BL; Abbott DH; Chazenbalk GD
    J Clin Endocrinol Metab; 2016 Nov; 101(11):4178-4188. PubMed ID: 27571186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Precocious subcutaneous abdominal stem cell development to adipocytes in normal-weight women with polycystic ovary syndrome.
    Fisch SC; Nikou AF; Wright EA; Phan JD; Leung KL; Grogan TR; Abbott DH; Chazenbalk GD; Dumesic DA
    Fertil Steril; 2018 Dec; 110(7):1367-1376. PubMed ID: 30503136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accelerated subcutaneous abdominal stem cell adipogenesis predicts insulin sensitivity in normal-weight women with polycystic ovary syndrome.
    Dumesic DA; Tulberg A; Leung KL; Fisch SC; Grogan TR; Abbott DH; Naik R; Chazenbalk GD
    Fertil Steril; 2021 Jul; 116(1):232-242. PubMed ID: 33341231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reproductive and metabolic determinants of granulosa cell dysfunction in normal-weight women with polycystic ovary syndrome.
    Guedikian AA; Lee AY; Grogan TR; Abbott DH; Largaespada K; Chazenbalk GD; Dumesic DA
    Fertil Steril; 2018 Mar; 109(3):508-515. PubMed ID: 29428312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized clinical trial: effect of low-dose flutamide on abdominal adipogenic function in normal-weight women with polycystic ovary syndrome.
    Dumesic DA; Winnett C; Lu G; Grogan TR; Abbott DH; Naik R; Chazenbalk GD
    Fertil Steril; 2023 Jan; 119(1):116-126. PubMed ID: 36400597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adipose Insulin Resistance in Normal-Weight Women With Polycystic Ovary Syndrome.
    Dumesic DA; Phan JD; Leung KL; Grogan TR; Ding X; Li X; Hoyos LR; Abbott DH; Chazenbalk GD
    J Clin Endocrinol Metab; 2019 Jun; 104(6):2171-2183. PubMed ID: 30649347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enlarged adipocytes in subcutaneous adipose tissue associated to hyperandrogenism and visceral adipose tissue volume in women with polycystic ovary syndrome.
    Echiburú B; Pérez-Bravo F; Galgani JE; Sandoval D; Saldías C; Crisosto N; Maliqueo M; Sir-Petermann T
    Steroids; 2018 Feb; 130():15-21. PubMed ID: 29273198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subcutaneous and omental fat expression of adiponectin and leptin in women with polycystic ovary syndrome.
    Carmina E; Chu MC; Moran C; Tortoriello D; Vardhana P; Tena G; Preciado R; Lobo R
    Fertil Steril; 2008 Mar; 89(3):642-8. PubMed ID: 17562334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Global adiposity and thickness of intraperitoneal and mesenteric adipose tissue depots are increased in women with polycystic ovary syndrome (PCOS).
    Borruel S; Fernández-Durán E; Alpañés M; Martí D; Alvarez-Blasco F; Luque-Ramírez M; Escobar-Morreale HF
    J Clin Endocrinol Metab; 2013 Mar; 98(3):1254-63. PubMed ID: 23386652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ultrasonographic extended-view technique for evaluation of abdominal fat distribution in lean women with polycystic ovary syndrome.
    Battaglia C; Battaglia B; Mancini F; Paradisi R; Fabbri R; Venturoli S
    Acta Obstet Gynecol Scand; 2011 Jun; 90(6):600-8. PubMed ID: 21401530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Androgen excess and metabolic disorders in women with PCOS: beyond the body mass index.
    Condorelli RA; Calogero AE; Di Mauro M; Mongioi' LM; Cannarella R; Rosta G; La Vignera S
    J Endocrinol Invest; 2018 Apr; 41(4):383-388. PubMed ID: 28942551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin and androgen relationships with abdominal body fat distribution in women with and without hyperandrogenism.
    Pasquali R; Casimirri F; Cantobelli S; Labate AM; Venturoli S; Paradisi R; Zannarini L
    Horm Res; 1993; 39(5-6):179-87. PubMed ID: 8314200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin-like factor 3: a new circulating hormone related to luteinizing hormone-dependent ovarian hyperandrogenism in the polycystic ovary syndrome.
    Gambineri A; Patton L; De Iasio R; Palladoro F; Pagotto U; Pasquali R
    J Clin Endocrinol Metab; 2007 Jun; 92(6):2066-73. PubMed ID: 17356050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Normo- and hyperandrogenic women with polycystic ovary syndrome exhibit an adverse metabolic profile through life.
    Pinola P; Puukka K; Piltonen TT; Puurunen J; Vanky E; Sundström-Poromaa I; Stener-Victorin E; Lindén Hirschberg A; Ravn P; Skovsager Andersen M; Glintborg D; Mellembakken JR; Ruokonen A; Tapanainen JS; Morin-Papunen LC
    Fertil Steril; 2017 Mar; 107(3):788-795.e2. PubMed ID: 28089571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polycystic ovaries at ultrasound: normal variant or silent polycystic ovary syndrome?
    Catteau-Jonard S; Bancquart J; Poncelet E; Lefebvre-Maunoury C; Robin G; Dewailly D
    Ultrasound Obstet Gynecol; 2012 Aug; 40(2):223-9. PubMed ID: 22648908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome.
    Pasquali R; Gambineri A; Biscotti D; Vicennati V; Gagliardi L; Colitta D; Fiorini S; Cognigni GE; Filicori M; Morselli-Labate AM
    J Clin Endocrinol Metab; 2000 Aug; 85(8):2767-74. PubMed ID: 10946879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Free androgen index and Irisin in polycystic ovary syndrome.
    Li H; Xu X; Wang X; Liao X; Li L; Yang G; Gao L
    J Endocrinol Invest; 2016 May; 39(5):549-56. PubMed ID: 26584566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum Testosterone to Androstenedione Ratio Predicts Metabolic Health in Normal-Weight Polycystic Ovary Syndrome Women.
    Dumesic DA; Tulberg A; McNamara M; Grogan TR; Abbott DH; Naik R; Lu G; Chazenbalk GD
    J Endocr Soc; 2021 Nov; 5(11):bvab158. PubMed ID: 34661039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atherogenic metabolic profile in PCOS patients: role of obesity and hyperandrogenism.
    Castelo-Branco C; Steinvarcel F; Osorio A; Ros C; Balasch J
    Gynecol Endocrinol; 2010 Oct; 26(10):736-42. PubMed ID: 20569105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relation of intra-abdominal fat distribution to metabolic disorders in nonobese patients with polycystic ovary syndrome.
    Yildirim B; Sabir N; Kaleli B
    Fertil Steril; 2003 Jun; 79(6):1358-64. PubMed ID: 12798883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.